Active Not RecruitingNCT04101877
The Sahlgrenska Anti-VEGF Study
PHASE2 · 402 planned enrolment
- Countries listed
- 1
- Registry update
- November 21, 2025
immortal.lifeTrial registrations containing the exact intervention label Bevacizumab Injection.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 402 planned enrolment
Phase not reported · 38 planned enrolment
Phase not reported · 48 planned enrolment